Lantern Pharma, Inc. (LTRN)
1.77
+0.15
(+9.26%)
USD |
NASDAQ |
Apr 07, 16:00
1.77
0.00 (0.00%)
After-Hours: 16:19
Lantern Pharma SG&A Expense (TTM) : 6.464M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.753B |
| BioVie, Inc. | 8.194M |
| Acurx Pharmaceuticals, Inc. | 6.230M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |